Dissecting high from low responders in a vitamin D3 intervention study.
J Steroid Biochem Mol Biol. 2014 Nov 13. pii: S0960-0760(14)00267-2. doi: 10.1016/j.jsbmb.2014.11.012. [Epub ahead of print]
Saksa N1, Neme A1, Ryynänen J1, Uusitupa M2, de Mello VD2, Voutilainen S2, Nurmi T2, Virtanen JK2, Tuomainen T2, Carlberg C3.
1 School of Medicine, Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland.
2 Institute of Public Health and Clinical Nutrition, University of Eastern Finland, FIN-70211 Kuopio, Finland.
3 School of Medicine, Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, FIN-70211 Kuopio, Finland. Electronic address: carsten.carlberg at uef.fi.
Vitamin D3 is a pleiotropic signaling molecule that has via activation of the transcription factor vitamin D receptor (VDR) a direct effect on the expression of more than 100 genes. The aim of this study was to find transcriptomic and clinical biomarkers that are most suited to identify vitamin D3 responders within 71 pre-diabetic subjects during a 5-month intervention study (VitDmet). In hematopoietic cells, the genes ASAP2, CAMP, CD14, CD97, DUSP10, G0S2, IL8, LRRC8A, NINJ1, NRIP1, SLC37A2 and THBD are known as primary vitamin D targets.
We demonstrate that each of these 12 genes carries a conserved VDR binding site within its genomic region and is expressed in human peripheral blood mononuclear cells (PBMCs). The changes in the expression of these genes in human PBMCs at the start and the end of the vitamin D-intervention were systematically correlated with the alteration in the circulating form of vitamin D3, 25-hydroxyvitamin D3 (25(OH)D3).
Only 39-44 (55-62%) of the study subjects showed a highly significant response to vitamin D3, i.e., we considered them as "responders".
In comparison, we found for 37-53 (52-75%) of the participants that only 12 biochemical and clinical parameters, such as concentrations of parathyroid hormone (PTH) and insulin, or computed values, such as homeostatic model assessment and insulin sensitivity index, show a correlation with serum 25(OH)D3 levels that is as high as that of the selected VDR target genes.
All 24 parameters together described the pleiotropic vitamin D response of the VitDmet study subjects. Interestingly, they demonstrated a number of additional correlations that define a network, in which PTH plays the central role.
In conclusion, vitamin D3-induced changes in human PBMCs can be described by transcriptomic and serum biomarkers and allow a segregation into high and low responders. This article is part of a Special Issue entitled '17th Vitamin D Workshop' .
PMID: 25448738
Publisher wants $36 for the PDF
See also Vitamin D Life
- Reasons for low response to vitamin D genes about 30% - some other causes are much more important
- Vitamin D Binding Protein special Issue – June 2014
- Role of Vitamin D in human Diseases and Disorders – An Overview – DBP, VDR June 2014
- Testing misses the Vitamin D tied up with VDBP – June 2014
in some cases the body gets as much benefit, but the tests do not account for it - Blood tests can be a poor measure of actual vitamin D due to D Binding Protein (DBP) – May 2014
- 24 ng lower response to Vitamin D due to obesity, low initial Vitamin D, and genetics – RCT Feb 2015
- Reasons for low response to vitamin D
Click on chart for details